Kevin C. Tang, Director, 10% Owner at LA JOLLA PHARMACEUTICAL CO (LJPC), bought 160,000 shares at $16.19 ($2.9M) on 2016-03-01, disclosed to the SEC on 2016-03-03.
Open-market purchase of $2.9M LJPC by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.13 | 20,000 | $323K | 11.3% |
| 2 | $16.19 | 20,000 | $324K | 11.4% |
| 3 | $16.94 | 15,972 | $271K | 9.5% |
| 4 | $17.86 | 4,028 | $72K | 2.5% |
| 5 | $18.08 | 20,000 | $362K | 12.7% |
| 6 | $18.77 | 6,500 |
| $122K |
| 4.3% |
| 7 | $18.55 | 20,000 | $371K | 13.0% |
| 8 | $18.72 | 20,000 | $374K | 13.1% |
| 9 | $18.91 | 13,500 | $255K | 9.0% |
| 10 | $18.93 | 20,000 | $379K | 13.3% |
| Total | $17.82 avg | 160,000 | $2.9M | 100% |
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |